Casdin Capital DNABW Position
Active3-Fund ConvergenceCasdin Capital held their position in Ginkgo Bioworks Holdings, Inc. (DNABW) in Q4 2025, holding $303K worth of shares across 36,493 shares.
The position was first reported in Q1 2024 and has been tracked across 8 quarterly 13F filings.
DNABW is a convergence signal: 3 specialist biotech funds hold this stock, suggesting high institutional conviction.
Casdin Capital DNABW Position History
Frequently Asked Questions
Does Casdin Capital own DNABW?
Yes. As of Q4 2025, Casdin Capital holds 36,493 shares of Ginkgo Bioworks Holdings, Inc. (DNABW) valued at $303K. This data comes from their SEC 13F filing.
How many hedge funds own DNABW?
3 specialist biotech hedge funds currently hold DNABW, including EcoR1 Capital, Deerfield Management. When 3 or more specialist funds hold the same stock, BiotechEdge flags it as a convergence signal.
When did Casdin Capital first buy DNABW?
Casdin Capital's position in DNABW was first reported in Q1 2024. 13F filings are reported with a 45-day delay, so the actual purchase may have occurred earlier in the quarter.
Is Casdin Capital's DNABW position increasing or decreasing?
Casdin Capital held their DNABW position unchanged in the most recent quarter.
Get the weekly biotech signal briefing
Fund moves, convergence shifts, insider buys, and catalyst alerts — delivered free every Monday.
DNABWCompany Page →
All fund holders, insider trades, catalysts, and cash runway
Casdin CapitalPortfolio →
Full 13F holdings, sector breakdown, and top movers
Drill into any signal
Fund Convergence
See which stocks multiple specialist funds are buying at once
Catalyst Calendar
Every PDUFA date, Phase 3 readout, and AdCom in one view
Insider Trading
When executives buy their own stock — the strongest bullish signal
Cash Runway
Which biotechs are running low on cash and face dilution risk
Short Squeeze
High short interest + fund buying + upcoming catalyst = squeeze setup
Signal Rankings
Every signal in one composite score — ranked by conviction
Biotech Movers
Stocks with the most signal activity right now across all signals
13F Changes
What top biotech funds bought and sold in the latest 13F filing
Want AI context on every signal? Start free trial →